Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2019
Cash flows from operating activities:
Net income	$ 474,505	$ 621,674	$ 404,592
Adjustment to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	156,758	154,850	150,795
Amortization of right-of-use-assets	34,760	26,523
Stock-based compensation costs (note 11)	63,927	57,559	52,073
Loss attributable to equity method investments (note 6)	11,205	25,058	15,833
(Gain) loss on equity investments (note 6)	(14,515)	14,519	15,007
Restructuring expenses (note 19)	8,673		9,401
Gain on previously held equity interest			(1,909)
Changes in fair value of business combination contingent consideration		(7)	(286)
Changes in operating assets and liabilities:
Accounts receivable	(129,195)	54,383	(18,013)
Inventories	(21,954)	(69,881)	(84,188)
Prepaid expenses, net deferred income taxes and other current assets	(58,154)	(58,999)	(47,575)
Accounts payable, accrued expenses and other	210,708	(23,424)	(27,278)
Net cash provided by operating activities	736,718	802,255	459,051
Cash flows from investing activities:
Purchases of property, plant and equipment	(102,712)	(95,330)	(68,710)
Patent registration costs	(14,114)	(10,608)	(8,632)
Business acquisitions, net of cash acquired	(39,067)	(27,910)	(951,383)
Purchases of investments (note 6)	(21,788)	(31,616)	(46,717)
Proceeds on maturity of foreign currency contracts	19,219	(14,397)	(264)
Net cash used in investing activities	(158,462)	(179,861)	(1,075,706)
Cash flows from financing activities:
Proceeds from issuance of common stock, net	37,790	48,182	36,727
Taxes paid related to net share settlement of equity awards	(50,209)	(46,061)	(28,104)
Purchases of treasury stock			(22,844)
Payments of business combination contingent consideration	(3,500)	(302)	(909)
Proceeds from borrowings, net of borrowing costs	90,000	1,190,000	1,519,230
Repayment of borrowings	(612,000)	(1,284,012)	(711,745)
Dividends paid	(226,713)	(225,093)	(211,712)
Net cash used in financing activities	(764,632)	(317,286)	580,643
Effect of exchange rate changes on cash	18,498	10,920	(5,561)
Net increaase (decrease) in cash and cash equivalents	(167,878)	316,028	(41,573)
Cash and cash equivalents at beginning of period	463,156	147,128	188,701
Cash and cash equivalents at end of period	295,278	463,156	147,128
Supplemental disclosure of cash flow information:
Income taxes paid, net of refunds	221,359	180,359	242,860
Interest paid	23,989	40,377	36,156
Fair value of assets acquired, excluding cash	16,671	14,919	429,522
Liabilities assumed	(1,543)	(4,292)	(265,217)
Goodwill on acquisition	24,671	20,375	794,320
Deferred payments	(3,768)	(408)	7,242
Fair value of contingent consideration		(3,500)
Cash paid for acquisitions	$ 43,567	$ 27,910	$ 951,383